InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 191297

Monday, 09/22/2014 10:13:18 AM

Monday, September 22, 2014 10:13:18 AM

Post# of 346408

Invited Speakers:

Costas Baxevanis
Greece



nice... didn't even notice Costas B. - out of St. Savas Cancer Hospital in Greece and I've seen the name pop up many times before on the PAV list of Sonja Perez- Director of Immune Montioring Lab

gr.linkedin.com/pub/constantin-baxevanis/27/956/5a

-------------------------

Big Pharma can't pay off every single Doctor and there comes a point, when the results are in.... Big Pharma will be on the losing end of this battle

Bavi is here to stay

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News